Welcome to our dedicated page for Matson SEC filings (Ticker: MATX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Matson, Inc. filings document a public ocean transportation and logistics company with recurring disclosures on operating results, capital allocation, governance, and executive matters. Recent Form 8-K reports furnish earnings releases, preliminary results, investor presentations, dividend actions, and share repurchase program updates tied to the company’s Ocean Transportation and Logistics operations.
Matson’s proxy and annual-meeting filings cover director elections, advisory votes on executive compensation, auditor ratification, compensation tables, and shareholder voting outcomes. Other current reports record leadership-transition disclosures and Regulation FD presentation materials, providing formal records of governance actions and public-company communications for MATX.
A group of American Century entities, including American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research, reports beneficial ownership of Matson, Inc. common stock. American Century ETF Trust holds 1,676,889 shares with sole voting and dispositive power, representing 5.5% of the outstanding common stock. The other American Century entities and Stowers Institute report beneficial ownership of 1,760,017 shares, representing 5.8% of the class, all with sole voting and dispositive power and no shared power.
The securities are held on behalf of various investment companies and institutional accounts advised by American Century Investment Management, Inc., and no single client advised by it owns more than 5% of the class.
Matson, Inc. (MATX) has a planned sale of restricted common stock under Rule 144. Jason Taylor has filed to potentially sell 1,961 shares of common stock through Fidelity Brokerage Services LLC on or after August 13, 2026, with an indicated aggregate market value of $425,537.00. The filing states that 29,903,458 common shares are outstanding. It also lists prior compensation-related restricted stock vesting events in 2024 and 2025 and notes that Taylor sold 1,650 shares of common stock in the past three months for proceeds of $300,696.00.
Matson, Inc. insider John Warren Sullivan, a Senior Vice President, reported a sale of common stock. On 2026-08-11, he sold 1,917 shares at a price of $208.49 per share in a transaction described as a sale in the open market or a private transaction. Following this sale, he directly holds 7,630 shares of Matson common stock. The filing indicates the Rule 10b5-1 plan checkbox was not selected.
Matson, Inc. senior vice president Jennifer C. Tungul reported a sale of 402 shares of common stock on 2026-08-11 in a transaction classified as a sale in open market or private transaction. The shares were sold at an average price of $208.49 per share, and following the transaction she held 5,852 shares of Matson common stock directly. The Rule 10b5-1 checkbox was left unchecked, so the filing does not state that this sale was made under a trading plan.
Matson, Inc. senior vice president Kuuhaku T Park reported a sale of 1,000 shares of Matson common stock on August 11, 2026, in an open-market or private transaction at $208.49 per share. Following this transaction, Park directly holds 9,984.313 shares of Matson common stock.
Matson, Inc. Senior Vice President Leonard P. Isotoff reported a sale of 1,250 shares of common stock on 2026-08-11 in an open market or private transaction at a weighted average price of $208.2963 per share. Following this transaction, he holds 6,527.132 shares of Matson common stock directly. The sale price reflects multiple trades executed between $208.055 and $209.00 per share.
Matson, Inc. (MATX) has a notice related to a potential sale of common stock under Rule 144. The securities section lists 1,917 common shares, an associated figure of 399,675.33, and 29,903,458 shares outstanding, with an approximate sale date of August 11, 2026 on the NYSE. The filing also records prior issuer grants labeled as restricted stock vesting awards of 250, 405, and 1,262 common shares received as compensation on January 24, 2022, January 23, 2023, and January 25, 2023, respectively.
An affiliate of MATX filed to resell common stock. The filer plans to sell 1,000 shares of common stock held at Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $203,275.80, on or after August 11, 2026. The disclosure also lists prior equity activity, including restricted stock vesting of 972 shares on January 26, 2025 and 28 shares on January 22, 2026 as compensation, and a past sale on May 12, 2026 of 2,500 shares of common stock for $450,475.00.